On 16 Januari 2023 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 4 year period of ineligibility on the Athlete Radha after she tested positive for the prohibited substance Erythropoietin (EPO).

Hereafter the Athlete appealed the ADDPI decision with the Anti-Doping Appeal Panel of India (ADAPI). The Athlete requested the Appeal Panel to set aside the Appealed Decision and to impose a reduced sanction.

The Athlete denied the intentional use of the substance and claimed that she acted with No Significant Fault or Negligence. She explained with medical records that she had used prescribe medications as treatment for her diagnosed condition.

Further the Athlete asserted that she was hampered in her defence due problems with her original e-mail account. As a result she was unaware of the hearing, nor notified about the decision rendered by the ADDPI.

The India National Anti-Doping Agency (INADA) contended that a prohibited substance had been established in the Athlete's sample and that the Athlete had no valid TUE. Furthermore her medical treatment could not explain the presence of EPO in her sample.

Also INADA contended that the Athlete had admitted the violation and had acted negligently with her medication. Moreover there was sufficient e-mail evidence that showed that the Athlete was aware of the proceedings.

The Appeal Panel assessed the evidence in this case and determines that:

• The presence of a prohibited substance had been established in the Athlete's sample and accordingly she had committed an anti-doping rule violation.
• The Athlete's medical reports and prescribed medication could not explain the use and presence of EPO.
• The Athlete failed to demonstrate the source of EPO.
• E-mail correspondence showed that the Athlete was aware of the proceedings and that she didn't care.

Therefore the ADAPI Panel decides on 18 December 2023 to uphold the Appealed Decision and the imposed 4 year period of ineligibility.

In August 2023 the Anti-Doping Agency of Kenya (ADAK) reported and anti-doping rule violation against the Athlete Betty Chelangat after her sample tested positive for the prohibited substance Methasterone.

Following notification the Athlete timely admitted the violation, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by ADAK.

ADAK deems that the Athlete's violation was intentional and determines that she shall receive a 1 year reduction for her timely admission of the anti-doping rule violation.

Therefore ADAK decides on 14 December 2023 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 12 September 2023.

The Moroccan Athlete Fouad Idbafdil participated in marathons in Marocco in May 2022, the United Arab Emirates in November 2022 and Saudi Arabia in February 2023 where he provided his samples.

Hereafter in March 2023 the Moroccan Anti-Doping Agency (AMAD) and in April 2023 the Athletics Integrity Unit (AIU) reported multiple anti-doping rule violations against the Athlete after his samples tested positive for the prohibited substances Erythropoietin (EPO) and Methoxy polyethylene glycol-epoetin beta (CERA).

Following notification by AMAD in March 2023 a provisional suspension was ordered. Initially the Athlete denied the intentional use of the substances and requested the AIU for a hearing. He stated that he previously had received medical treatments. However the AIU established that these treatments could not explain the positive test results.

Ultimately in December 2023 the Athlete admitted the violation, waived his right for a hearing and signed and submitted the Admission of Anti-Doping Rule Violations and Acceptance of Consequences Form.

The AIU finds that the Athlete's 3 anti-doping rule violations shall be considered together as one single first violation. Furthermore the AIU deems that there are aggravating circumstances present in this case because the Athlete had used 2 prohibited substances for months.

Therefore the AIU decides on 14 December 2023 to impose a 6 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 14 March 2023.

In August 2023 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported an anti-doping rule violation against the Colombian Athlete John Tello Zuniga after his A and B samples tested positive for the prohibited substance Erythropoietin (EPO).

Following notification the Athlete timely admitted the violation in November 2023, waived his right for a hearing and accepted the sanction proposed by the AIU.

The AIU deems that the Athlete failed to demonstrate that the violation was not intentional. Because he had signed and submitted the Admission of Anti-Doping Rule Violations and Acceptance of Consequences Form he received a 1 year reduction from the AIU.

Therefore the AIU decides on 13 December 2023 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 25 August 2023.

In May 2022 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported an anti-doping rule violation against the Kenyan Athlete Joyce Chepkemoi Tele after her sample tested positive for the prohibited substance Triamcinolone Acetonide. Following notification a provisional suspension was ordered and the Athlete filed a statement in her defence.

The Athlete explained that she underwent medical treatment in a hospital in Kenya in April 2022 for her diagnosed pneumonia and an allergic reaction. She demonstrated with documents that she had received various medications including a Trinocort injection containing Triamcinolone Acetonide.

Hereafter in July 2022 the Athlete's application for a retroactive TUE was rejected by the TUE Committee of the Anti-Doping Agency of Kenya (ADAK). Furthermore ADAK's investigation confirmed her statements regarding the medical treatment she underwent in the hospital.

The AIU concludes that the Athlete's violation was not intentional and deems that there are grounds for a reduced sanction. Thereupon the Athlete admitted the violation and signed an Admission of Anti-Doping Rule Violations and Acceptance of Consequences Form.

Therefore the AIU decides on 13 December 2023 to impose an 18 month period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. 27 June 2022.

In September 2023 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported an anti-doping rule violation against the Kenyan Athlete Rebecca Jepchirchir Korir after her sample tested positive for the prohibited substance Methylprednisolone.

Following notification the Athlete explained that she had used painkillers for her injury that might have caused the positive test. Although the violation was considered not intentional the AIU finds that she failed to explain how the prohibited substance had entered her system.

Thereupon a provisional suspension was ordered and the Athlete failed to respond to the AIU communications. Because she did not respond within the set deadline the AIU determines in November 2023 that the Athlete was deemed to have waived her right for a hearing and accepted the consequences.

Therefore the AIU decides on 13 December 2023 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 2 November 2023.

NADO Flanders reported two anti-doping rule violations against the weightlifter for use and possession after the police found in the Athlete's residence in November 2022 the prohibited substance Metandienone Boldenone, Nandrolone, Oxymetholone and Testosterone. 

After notification the Athlete failed to attend the hearing of the NADO Flanders Disciplinary Commission and a Decision was rendered in absentia of the Athlete.

Prior the Athlete had admitted these violations and stated that he had followed a course of treatment 5 or 6 times. In view of the evidence the Commission determines that the Athlete possessed a high number of prohibited substances and intentionally had used these banned products

Therefore the NADO Flanders Disciplinary Commission decides on 12 December 2023 to impose a fine and a 2 year period of ineligibility on the Athlete, starting on the date of the decision.

Fees and expenses for this Commission shall be borne partially by the Athlete.

In 2023 NADO Flanders reported two anti-doping rule violations against the weightlifter for possession and use of a prohibited substance. Previously the police had informed NADO Flanders that in April 2023 they had found Stanozolol in possession of the Athlete.

After notification the Athlete was heard for the NADO Flanders Disciplinary Commission. The Athlete admitted the violations and stated that he had purchased this product online.

In view of the evidence and the admission the Commission finds that the Athlete intentionally had committed these anti-doping rule violations.

Therefore the NADO Flanders Disciplinary Commission decides on 12 December 2023 to impose a fine and a 2 year period of ineligibility on the Athlete, starting on the date of the decision.

Fees and expenses for this Commission shall be borne partially by the Athlete.

In 2023 NADO Flanders reported two anti-doping rule violations against the weightlifter for possession and use of prohibited substances. After notification the Athlete was heard for the NADO Flanders Disciplinary Commission.

Previously the police had informed NADO Flanders that in July 2022 they had found Cannabis in possession of the Athlete. Thereupon the police searched his residence and found a large number of products containing multiple prohibited substances:

• Dehydrochlormethyltestosterone;
• Mesterolone;
• Metandienone;
• Nandrolone;
• Oxandrolone;
• Oxymetholone;
• Stanozolol; and
• Testosterone.

The Athlete admitted the possession and stated that he had used these substances for 2 years. Prior he had used prescription Testosterone and because of the costs he purchased it on the internet.

In view of the evidence and the admission the Commission finds that the Athlete intentionally had committed these anti-doping rule violations.

Therefore the NADO Flanders Disciplinary Commission decides on 12 December 2023 to impose a fine and a 2 year period of ineligibility on the Athlete, starting on the date of the decision.

Fees and expenses for this Commission shall be borne partially by the Athlete.

In May 2023 NADO Flanders reported an anti-doping rule violation against the Lithuanian Athlete after his sample tested positive for the prohibited substances 19-norandrosterone,19-noretiocholanolone (Nandrolone) Boldenone and Stanozolol.

After notification the Athlete failed to attend the hearing of the NADO Flanders Disciplinary Commission and a Decision was rendered in absentia of the Athlete.

The Commission finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.

Therefore the NADO Flanders Disciplinary Commission decides on 12 December 2023 to impose a fine and a 2 year period of ineligibility on the Athlete, starting on the date of the decision.

Fees and expenses for this Commission shall be borne partially by the Athlete.